The researchers plan to develop a cognitive training and physical exercise program — delivered to patients’ homes via telemedicine — and test whether such a program could decrease dementia in patients who experienced delirium while in a hospital’s intensive care unit. Delirium is a type of acute brain failure affecting 70 percent of older ICU patients, which predisposes them to long-term disabilities like dementia.
The researchers will conduct a trial of 300 seniors who are former ICU patients. Each patient will undergo one of four home-based telemedicine programs, which will coach participants through a mix of cognitive training, physical exercise and brain health counseling. The researchers will provide participants with computers and wireless internet access for the study’s video conferences.
The NIH’s National Institute on Aging awarded the researchers a $3.48 million grant for the study.
More articles on telehealth:
eClinicalWorks unveils telehealth solution
Pennsylvania healthcare network taps Teladoc to reduce readmissions
Patients may prefer hearing ‘serious’ healthcare results via video, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
